Caribou Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Caribou Biosciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 149% to $34,477,000. Profit margin reached -296%. Total operating expenses were $150,536,000.
Profit Margin
| 2019 | 5.78M | -23.43M | -404.82% |
|---|---|---|---|
| 2020 | 12.36M | -34.30M | -277.55% |
| 2021 | 9.59M | -66.92M | -697.26% |
| 2022 | 13.85M | -99.42M | -717.79% |
| 2023 | 34.47M | -102.07M | -296.05% |
CRBU Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 34.47M | 13.85M | 9.59M | 12.36M | 5.78M |
Cost of revenue | 112.07M | 3.64M | 984K | 34.42M | 23.63M |
Gross profit | -77.59M | 10.21M | 8.61M | -22.06M | -17.84M |
Operating exp. | |||||
Research and development | 112.07M | 82.23M | 52.25M | 34.42M | 23.63M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 150.53M | 120.25M | 76.57M | 48.48M | 40.09M |
Operating income | -116.05M | -106.39M | -66.97M | -36.12M | -34.30M |
Other income (expenses), net | 14.18M | 7.04M | 377K | -3K | 3.33M |
Income before tax | -101.87M | -99.35M | -66.60M | -36.12M | -30.96M |
Income tax expense | 193K | 70K | 321K | -1.81M | -7.53M |
Net income | -102.07M | -99.42M | -66.92M | -34.30M | -23.43M |
Earnings per share | |||||
Basic EPS | -1.38 | -1.64 | -1.11 | -0.57 | -0.39 |
Diluted EPS | -1.38 | -1.64 | -1.11 | -0.57 | -0.39 |
| Data source | Data source | Data source |